Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR) is a research paper published in EClinicalMedicine (2020). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: 1R01 CA102713
NCI NIH HHS
Grant: R01 CA102713
American Cancer Society
Indiana University
McGill University
University of New Mexico
Saint Louis University
U.S. Food and Drug Administration
University of North Carolina at Chapel Hill
University of Texas MD Anderson Cancer Center
University of Utah
Tulane University
University of Miami
Università di Pisa
Université Pierre et Marie Curie
Johns Hopkins University
University of California
Yale University
Københavns Universitet
University of Chicago
University of Pennsylvania
University of Texas at San Antonio
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Food and Drug Administration
Medical University of South Carolina
Stanford University
University of Melbourne
Baylor University
Case Western Reserve University
Health Sciences Center, University of Oregon
National Institutes of Health
FWCI
0.56
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals